Riskpilot← Back to searchSign inGet full accessHi - Tec Implants Finland Oy Ltd.
OYActiveY-tunnus 1102132-5Kauppakatu 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19971 employees
Revenue 2024
EUR 9K
-20% vs 2023
EBITDA margin
33.5%
-17% vs 2023
Equity ratio
93.9%
Financial strength
Net profit 2024
EUR 2K
-16% vs 2023
| Revenue | EUR 9K | -20% |
| EBITDA | EUR 3K | -17% |
| Net profit | EUR 2K | -16% |
| Total assets | EUR 34K | +4% |
| Equity | EUR 32K | +0% |
| Employees | 1 | — |
Legal name
Hi - Tec Implants Finland Oy Ltd.
Y-tunnus number
1102132-5
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. lokakuuta 1997
Share capital
EUR 2 523
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on hammas- ja lääketieteellisten tarvikkeiden kauppa ja maahan tuonti ja maasta vienti. Hammaslääketieteellinen konsultointi, koulutus, suunnittelu ja rakentaminen. Yhtiö voi omistaa kiinteistöjä, muiden yhtiöiden osakkeita j käydä kauppaa niillä.
Address
Kauppakatu 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 | 14 | 14 | 12 | 9 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | −7 | 7 | 1 | 4 | 3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | 7 | 1 | 4 | 3 |
| Net financials | −0 | −0 | 0 | −0 | 0 |
| Profit before tax | −7 | 7 | 1 | 4 | 3 |
| Tax | −0 | 0 | 0 | 1 | 1 |
| Net profit | −7 | 7 | 1 | 3 | 2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 28 | 34 | 32 | 33 | 34 |
| Equity | 27 | 34 | 32 | 32 | 32 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 1 | 1 | 1 | 1 | 2 |
| Total debt | 1 | 1 | 1 | 1 | 2 |
EBITDA margin
33.5%
This company
15.8%
Market median
+112% vs market
20202024
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
7.7%
This company
18.4%
Market median
-58% vs market
20202024
Net profit margin
26.7%
This company
8.1%
Market median
+230% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AM Chief Executive Officer | Chief Executive Officer | 1998 |
PJ Deputy Member | Deputy Member | 1998 |
| Former (2) | ||
VT | Audit | 2004 – 2022 |
MA Deputy auditor | Deputy auditor | 2004 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 1998 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hi - Tec Implants Finland Oy Ltd. also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Veijo Tapani Uusi-Uitto | Audit | 0 companies |
| Anne Marjatta Laihanen | Chief Executive Officer | 0 companies |
| Pertti Juhani Salmensuu | Deputy Member | 0 companies |
| Martti Antero Halko | Deputy auditor | 0 companies |
| Risto Carl-Håkan Sandberg | Board of Directors | 0 companies |
| Harri Juha Sandberg | Board of Directors | 0 companies |